N@N

Here's Why Astrazeneca (AZN) is a Strong Momentum Stock

The article from MSN Money discusses why AstraZeneca (AZN) is considered a strong momentum stock. It highlights that AstraZeneca has shown significant positive momentum in its stock price, with a 1.86% increase last week and a 10.8% rise over the past month, outperforming the Zacks Large Cap Pharmaceuticals industry. Over the last year, the stock has surged by 23.5%, compared to the S&P 500's 27.7% increase. The article points out that momentum investors look for stocks with strong price trends, and AstraZeneca fits this profile with its recent performance metrics. Additionally, the company's earnings estimates have been revised upwards, with the current quarter's estimates increasing by 1.86% and the full year's by 1.52% over the last 30 days. This positive revision in earnings estimates, combined with its stock price momentum, supports the argument for AstraZeneca being a strong momentum stock.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/savingandinvesting/here-s-why-astrazeneca-azn-is-a-strong-momentum-stock/ar-AA1vkS0e ]